Resideo Technologies IncREZI
Price$18.17Intrinsic value$24.1333% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $7.7B+13.2% YoYTTM through 4 Jul 2026
Net Income $427M+268.1% YoYTTM through 4 Jul 2026
Free Cash Flow -$1.4BTTM through 4 Jul 2026

Margins

Current
Gross Margin28.8%
EBITDA Margin9.5%
Operating Margin5.3%
Net Margin5.6%

Returns

14.2%ROE
4.9%ROA
7.1%ROIC

Balance Sheet Health

Debt / Equity1.19x
Current Ratio2.22x
Net Debt$3B
Cash & Equivalents$549M

Quality Metrics

Altman Z-Score1.73
Piotroski F-Score5 / 9
FCF Margin-18.3%
Earnings-Beat Rate66.7%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $7.5B
Diluted EPS$2.56TTM
'19'20'21'22'23'24'25
FY2025: $-3.54

Dividend

No dividend

Capital Allocation

R&D Spend$187M
Capex Intensity1.7%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.